These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 7497862)

  • 21. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group.
    Holleman F; Schmitt H; Rottiers R; Rees A; Symanowski S; Anderson JH
    Diabetes Care; 1997 Dec; 20(12):1827-32. PubMed ID: 9405901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control.
    Clarke WL; Gonder-Frederick LA; Richards FE; Cryer PE
    Diabetes; 1991 Jun; 40(6):680-5. PubMed ID: 2040384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes.
    Fritsche A; Stefan N; Häring H; Gerich J; Stumvoll M
    Ann Intern Med; 2001 May; 134(9 Pt 1):729-36. PubMed ID: 11329230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin and beta-endorphin responses to hypoglycemia are reduced in well-controlled insulin-dependent diabetes mellitus.
    Kinsley BT; Levy CJ; Simonson DC
    Metabolism; 1996 Nov; 45(11):1434-40. PubMed ID: 8931651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial.
    Little SA; Speight J; Leelarathna L; Walkinshaw E; Tan HK; Bowes A; Lubina-Solomon A; Chadwick TJ; Stocken DD; Brennand C; Marshall SM; Wood R; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JAM
    Diabetes Care; 2018 Aug; 41(8):1600-1607. PubMed ID: 29661916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
    Dagogo-Jack SE; Craft S; Cryer PE
    J Clin Invest; 1993 Mar; 91(3):819-28. PubMed ID: 8450063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.
    Levy CJ; Kinsley BT; Bajaj M; Simonson DC
    Diabetes Care; 1998 Aug; 21(8):1330-8. PubMed ID: 9702443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects and correlates of blood glucose awareness training among patients with IDDM.
    Cox DJ; Gonder-Frederick LA; Lee JH; Julian DM; Carter WR; Clarke WL
    Diabetes Care; 1989 May; 12(5):313-8. PubMed ID: 2721340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia.
    ter Braak EW; Appelman AM; van de Laak M; Stolk RP; van Haeften TW; Erkelens DW
    Diabetes Care; 2000 Oct; 23(10):1467-71. PubMed ID: 11023138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes.
    Clarke WL; Cox DJ; Gonder-Frederick LA; Kovatchev B
    JAMA; 1999 Aug; 282(8):750-4. PubMed ID: 10463710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
    Fanelli C; Pampanelli S; Lalli C; Del Sindaco P; Ciofetta M; Lepore M; Porcellati F; Bottini P; Di Vincenzo A; Brunetti P; Bolli GB
    Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia.
    Jeha GS; Karaviti LP; Anderson B; Smith EO; Donaldson S; McGirk TS; Haymond MW
    Diabetes Technol Ther; 2005 Dec; 7(6):876-84. PubMed ID: 16386093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.
    Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P;
    Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.
    Wilson DM; Calhoun PM; Maahs DM; Chase HP; Messer L; Buckingham BA; Aye T; Clinton PK; Hramiak I; Kollman C; Beck RW;
    Diabetes Technol Ther; 2015 Jun; 17(6):385-91. PubMed ID: 25761202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.
    Korytkowski MT; Mokan M; Veneman TF; Mitrakou A; Cryer PE; Gerich JE
    Diabetes Care; 1998 Nov; 21(11):1939-43. PubMed ID: 9802747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study.
    Johansson UB; Adamson UC; Lins PE; Wredling RA
    Diabetes Metab; 2000 May; 26(3):192-6. PubMed ID: 10880892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study.
    Blasetti A; Di Giulio C; Tocco AM; Verrotti A; Tumini S; Chiarelli F; Altobelli E
    Pediatr Diabetes; 2011 Feb; 12(1):4-10. PubMed ID: 20723102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes.
    Weinstock RS; DuBose SN; Bergenstal RM; Chaytor NS; Peterson C; Olson BA; Munshi MN; Perrin AJ; Miller KM; Beck RW; Liljenquist DR; Aleppo G; Buse JB; Kruger D; Bhargava A; Goland RS; Edelen RC; Pratley RE; Peters AL; Rodriguez H; Ahmann AJ; Lock JP; Garg SK; Rickels MR; Hirsch IB;
    Diabetes Care; 2016 Apr; 39(4):603-10. PubMed ID: 26681721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.